Prostate Cancer
Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
September 25, 2023
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers.
September 25, 2023
Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis.
September 25, 2023
A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.
September 25, 2023
Circulating trans fatty acids are associated with prostate cancer in Ghanaian and American men.
September 25, 2023
Exploring the Association Between Online Health Information and Racial Disparities in Prostate Cancer.
September 25, 2023
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.
September 25, 2023
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.
September 25, 2023
Fifteen-Year Outcomes of the ProtecT Trial for Localized Prostate Cancer.
September 25, 2023
Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer.
September 25, 2023
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses.
September 25, 2023
A polygenic two-hit hypothesis for prostate cancer.
September 25, 2023
A Transgender Patient with Prostate Cancer: Lessons Learnt.
September 25, 2023
Aggressive Prostate Cancer Is Preventable and so Are Racial Disparities.
September 25, 2023
Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis.
September 25, 2023